Clearside Biomedical
A biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Learn more
Launch date
Employees
Market cap
€83.6m
Enterprise valuation
€58m (Public information from Sep 2024)
Share price
$1.3 CLSD
Alpharetta Georgia (HQ)
Authorizing premium user...